[go: up one dir, main page]

ES8505988A1 - A PROCEDURE FOR REGENERATION OF PURIFIED 6-FLUOR-4-CHROMANONE - Google Patents

A PROCEDURE FOR REGENERATION OF PURIFIED 6-FLUOR-4-CHROMANONE

Info

Publication number
ES8505988A1
ES8505988A1 ES534921A ES534921A ES8505988A1 ES 8505988 A1 ES8505988 A1 ES 8505988A1 ES 534921 A ES534921 A ES 534921A ES 534921 A ES534921 A ES 534921A ES 8505988 A1 ES8505988 A1 ES 8505988A1
Authority
ES
Spain
Prior art keywords
salt
sorbinil
soln
iia
pinane
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES534921A
Other languages
Spanish (es)
Other versions
ES534921A0 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Corp Belgium
Pfizer Corp SRL
Original Assignee
Pfizer Corp Belgium
Pfizer Corp SRL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/440,657 external-priority patent/US4431828A/en
Priority claimed from US06/440,641 external-priority patent/US4435578A/en
Application filed by Pfizer Corp Belgium, Pfizer Corp SRL filed Critical Pfizer Corp Belgium
Publication of ES534921A0 publication Critical patent/ES534921A0/en
Publication of ES8505988A1 publication Critical patent/ES8505988A1/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10Spiro-condensed systems
    • C07D491/107Spiro-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Hydrogenated Pyridines (AREA)

Abstract

Prepn. of sorbinil (I), or its pharmaceutically acceptable cationic salt, comprises (i) crystallising the (-)-3-aminomethyl pinane salt (IIa) of (I) from a soln. of racemic hydantoin of formula (III), and (ii) converting (IIa) to (I) or its salt. Alternatively, (a) either the (+)-3-aminomethyl pinane salt (IIb) or the (-)-2-amino-2-norpinane salt (IV) of the enantiomer of sorbinil is crystallised from a soln. of the racemic hydantoin of formula (III), (b) a concentrate of sorbinil is isolated from the mother liquor, (c) the quinine salt (V) of (I) is crystallised from a soln. of the concentrate; and (d) the quinine salt is converted to (I) or its salt. Also claimed are chiral amine salts of (I), i.e. (IIa), (IIb), (IV) and (V). (I) is a potent aldose reductase inhibitor, esp. useful in controlling the chronic complications of diabetes mellitus. Process gives good yields with much lower solvent vols., and avoids the use of a highly toxic resolving agent (brucine). The efficacy of the process is further enhanced by isolating and recycling the undesired enantiomer via 6-fluoro-4-chromanone.
ES534921A 1982-11-10 1984-08-06 A PROCEDURE FOR REGENERATION OF PURIFIED 6-FLUOR-4-CHROMANONE Expired ES8505988A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US44068682A 1982-11-10 1982-11-10
US06/440,657 US4431828A (en) 1982-11-10 1982-11-10 Regeneration of 6-fluoro-4-chromanone from by-products in the synthesis of sorbinil
US06/440,641 US4435578A (en) 1982-11-10 1982-11-10 Sorbinil by optical resolution of precursor 6-fluoro-4-ureidochroman-4-carboxylic acid

Publications (2)

Publication Number Publication Date
ES534921A0 ES534921A0 (en) 1985-06-16
ES8505988A1 true ES8505988A1 (en) 1985-06-16

Family

ID=27412063

Family Applications (3)

Application Number Title Priority Date Filing Date
ES527118A Expired ES8506040A1 (en) 1982-11-10 1983-11-08 A PROCEDURE FOR THE PREPARATION OF SORBINYL OR A PHARMACEUTICALLY ACCEPTABLE CATIONIC SALT.
ES534921A Expired ES8505988A1 (en) 1982-11-10 1984-08-06 A PROCEDURE FOR REGENERATION OF PURIFIED 6-FLUOR-4-CHROMANONE
ES534920A Expired ES8600269A1 (en) 1982-11-10 1984-08-06 A PROCEDURE FOR THE PREPARATION OF A CRYSTALLINE SALT OF THE ACID S-6-FLUOR-4-UREIDOCROMAN-4-CARBOXILICO

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES527118A Expired ES8506040A1 (en) 1982-11-10 1983-11-08 A PROCEDURE FOR THE PREPARATION OF SORBINYL OR A PHARMACEUTICALLY ACCEPTABLE CATIONIC SALT.

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES534920A Expired ES8600269A1 (en) 1982-11-10 1984-08-06 A PROCEDURE FOR THE PREPARATION OF A CRYSTALLINE SALT OF THE ACID S-6-FLUOR-4-UREIDOCROMAN-4-CARBOXILICO

Country Status (16)

Country Link
KR (1) KR870000867B1 (en)
AU (1) AU540399B2 (en)
BG (1) BG44206A3 (en)
CS (1) CS266560B2 (en)
DD (1) DD213924A5 (en)
DK (1) DK512683A (en)
ES (3) ES8506040A1 (en)
FI (1) FI77247C (en)
GR (1) GR79017B (en)
IL (2) IL70165A (en)
NO (1) NO161916C (en)
NZ (1) NZ206189A (en)
PL (1) PL139713B1 (en)
PT (1) PT77617B (en)
SU (1) SU1209030A3 (en)
YU (2) YU44867B (en)

Also Published As

Publication number Publication date
NO834086L (en) 1984-05-11
IL81648A0 (en) 1987-09-16
PT77617A (en) 1983-12-01
NO161916C (en) 1989-10-11
KR870000867B1 (en) 1987-04-30
GR79017B (en) 1984-10-02
KR840006806A (en) 1984-12-03
PL139713B1 (en) 1987-02-28
IL70165A0 (en) 1984-02-29
YU220383A (en) 1988-02-29
DK512683D0 (en) 1983-11-09
ES534921A0 (en) 1985-06-16
AU2110583A (en) 1984-05-17
CS827183A2 (en) 1989-04-14
YU140985A (en) 1986-04-30
CS266560B2 (en) 1990-01-12
FI77247B (en) 1988-10-31
NO161916B (en) 1989-07-03
FI834088L (en) 1984-05-11
NZ206189A (en) 1987-06-30
ES534920A0 (en) 1985-09-16
SU1209030A3 (en) 1986-01-30
AU540399B2 (en) 1984-11-15
ES527118A0 (en) 1985-06-16
YU43883B (en) 1989-12-31
IL70165A (en) 1987-12-20
ES8600269A1 (en) 1985-09-16
PT77617B (en) 1986-05-12
PL244460A1 (en) 1985-03-26
ES8506040A1 (en) 1985-06-16
YU44867B (en) 1991-04-30
DK512683A (en) 1984-05-11
BG44206A3 (en) 1988-10-14
FI834088A0 (en) 1983-11-08
DD213924A5 (en) 1984-09-26
FI77247C (en) 1989-02-10

Similar Documents

Publication Publication Date Title
PT1025067E (en) PROCESS FOR THE CRYSTALLIZATION OF STEREO-CHEMICALLY IMPAIRED COMPOUNDS
JPS56127379A (en) Hydantoin amine compound
ES8505988A1 (en) A PROCEDURE FOR REGENERATION OF PURIFIED 6-FLUOR-4-CHROMANONE
ZA937638B (en) Process for the purification of crude clavulanic acid
DE69304466D1 (en) Production of neem extracts
CA2301271A1 (en) Purification of a methanol stream
DE3366558D1 (en) Novel derivative of thienopyridinone, its preparation and its therapeutic use
ES2044908T3 (en) PROCEDURE FOR THE PRODUCTION OF QUINAZOLINE DERIVATIVES.
JPS63239279A (en) Novel substituted tetrahydrofuran derivative
EP0353538A3 (en) Process for the preparation of intermediates for the synthesis of diltiazem
GB2094301A (en) Improvements in or relating to organic compounds
CA2242954A1 (en) Process for producing glycidyl sulfonate derivatives
CA2127755A1 (en) Method for Crystallizing Methionine
GB2037752A (en) 2,5-inter-o-phenylene-3,4-dinor-pgf and pgi compounds
UA12840A1 (en) METHOD OF OBTAINING RIGHT-ROTARY OXYISOIDOLIDICH DERIVATIVES OR THEIR PHARMACEUTICALLY ACCEPTED SALTS
USH328H (en) Purification of cephalosporins
DK443587D0 (en) PROCEDURE FOR PREPARING SUBSTITUTED INDOLINO DERIVATIVES
AU7500187A (en) Substituted isoquinoline derivatives and anti-ulcer agents
IE922238A1 (en) Process for the preparation of the dextrorotatory isomer of an isoindolinone derivative
IE922237A1 (en) Process for the preparation of the optical isomers of a 2-aminonaphthyridine derivative
US4324889A (en) 2,5-Inter-o-phenylene-3,4-dinor-6,9α-epoxy-6β-5-iodo-PGF1 amides
ES2092191T3 (en) METHOD FOR PURIFYING NUCLEOSIDE DERIVATIVES.
DE3677816D1 (en) SYNTHESIS OF 3S, 4S-BOC-STATIN.
Radtke et al. Synthesis of [14C] cerivastatin
Axen et al. 2, 5-Inter-O-phenylene-3, 4-dinor-PGF 2 compounds

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19970203